Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IKBα/NF-κB signaling pathway

Journal of Nutritional Biochemistry

Volumn 26, Issue 3, 2015, Pages 293-302

  Jia, Zhenquan ^a   Nallasamy, Palanisamy ^a   Liu, Dongmin ^b   Shah, Halley ^a   Li, Jason Z ^c   Chitrakar, Rojin ^a   Si, Hongwei ^d   McCormick, John ^a   Zhu, Hong ^e   Zhen, Wei ^b   Li, Yunbo ^a,e  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d TENNESSEE STATE UNIVERSITY   (United States)

^e Sampson Regional Medical Center Dermatology Residency Director   (United States)

Author keywords

Luteolin; Mice; NF B; TNF ; Vascular inflammation

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LUTEOLIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; CCL2 PROTEIN, HUMAN; I KAPPA B; ICAM1 PROTEIN, HUMAN; NF-KAPPAB INHIBITOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA INTIMA; ARTICLE; CELL ADHESION; CELL INTERACTION; DIET SUPPLEMENTATION; DIETARY INTAKE; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MONOCYTE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULITIS; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; BLOOD; C57BL MOUSE; CELL CULTURE; CELL LINE; CHEMISTRY; CYTOLOGY; DIET THERAPY; DIETARY SUPPLEMENT; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; PATHOLOGY; RANDOMIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ANIMALIA; MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTA; CELL ADHESION; CELL LINE; CELLS, CULTURED; CHEMOKINE CCL2; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; LUTEOLIN; MACROPHAGES; MALE; MICE, INBRED C57BL; MONOCYTES; NF-KAPPA B; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS;

EID: 84927696925     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.11.008     Document Type: Article

References (60)

1. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
2. Mayer K., Merfels M., Muhly-Reinholz M., Gokorsch S., Rosseau S., Lohmeyer J., et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol Heart Circ Physiol 2002, 283:H811-H818.
3. Chen J.W., Chen Y.H., Lin F.Y., Chen Y.L., Lin S.J. Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler Thromb Vasc Biol 2003, 23:1559-1566.
4. Carluccio M.A., Siculella L., Ancora M.A., Massaro M., Scoditti E., Storelli C., et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 2003, 23:622-629.
5. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ Res 2007, 100:607-621.
6. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
7. Angel K., Provan S.A., Fagerhol M.K., Mowinckel P., Kvien T.K., Atar D. Effect of 1-year anti-TNF-alpha therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens 2012, 25:644-650.
8. Mukherjee T.K., Nathan L., Dinh H., Reddy S.T., Chaudhuri G. 17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. J Biol Chem 2003, 278:11746-11752.
9. Boyle E.M., Kovacich J.C., Canty T.G., Morgan E.N., Chi E., Verrier E.D., et al. Inhibition of nuclear factor-kappa B nuclear localization reduces human E-selectin expression and the systemic inflammatory response. Circulation 1998, 98:II282-II288.
10. Yerneni K.K., Bai W., Khan B.V., Medford R.M., Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 1999, 48:855-864.
11. Arts I.C., Hollman P.C. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005, 81:317S-325S.
12. Maron D.J. Flavonoids for reduction of atherosclerotic risk. Curr Atheroscler Rep 2004, 6:73-78.
13. Mennen L.I., Sapinho D., de Bree A., Arnault N., Bertrais S., Galan P., et al. Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr 2004, 134:923-926.
14. Cao J., Zhang Y., Chen W., Zhao X. The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake. Br J Nutr 2010, 103:249-255.
15. Nazari Q.A., Kume T., Takada-Takatori Y., Izumi Y., Akaike A. Protective effect of luteolin on an oxidative-stress model induced by microinjection of sodium nitroprusside in mice. J Pharmacol Sci 2013, 122:109-117.
16. Kanazawa K., Uehara M., Yanagitani H., Hashimoto T. Bioavailable flavonoids to suppress the formation of 8-OHdG in HepG2 cells. Arch Biochem Biophys 2006, 455:197-203.
17. Si H., Wyeth R.P., Liu D. The flavonoid luteolin induces nitric oxide production and arterial relaxation. Eur J Nutr 2014, 53:269-275.
18. Jang S., Dilger R.N., Johnson R.W. Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J Nutr 2010, 140:1892-1898.
19. Shimoi K., Okada H., Furugori M., Goda T., Takase S., Suzuki M., et al. Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 1998, 438:220-224.
20. Englisch W., Beckers C., Unkauf M., Ruepp M., Zinserling V. Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 2000, 50:260-265.
21. Gebhardt R. Prevention of taurolithocholate-induced hepatic bile canalicular distortions by HPLC-characterized extracts of artichoke (Cynara scolymus) leaves. Planta Med 2002, 68:776-779.
22. Li H., Xia N., Brausch I., Yao Y., Forstermann U. Flavonoids from artichoke (Cynara scolymus L.) up-regulate endothelial-type nitric-oxide synthase gene expression in human endothelial cells. J Pharmacol Exp Ther 2004, 310:926-932.
23. Babu P.V., Si H., Fu Z., Zhen W., Liu D. Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice. J Nutr 2012, 142:724-730.
24. Jia Z., Babu P.V., Si H., Nallasamy P., Zhu H., Zhen W., et al. Genistein inhibits TNF-alpha-induced endothelial inflammation through the protein kinase pathway A and improves vascular inflammation in C57BL/6 mice. Int J Cardiol 2013, 168:2637-2645.
25. Jia Z., Zhen W., Velayutham Anandh Babu P., Liu D. Phytoestrogen genistein protects against endothelial barrier dysfunction in vascular endothelial cells through PKA-mediated suppression of RhoA signaling. Endocrinology 2013, 154:727-737.
26. Nallasamy P., Si H., Babu P.V., Pan D., Fu Y., Brooke E.A., et al. Sulforaphane reduces vascular inflammation in mice and prevents TNF-alpha-induced monocyte adhesion to primary endothelial cells through interfering with the NF-kappaB pathway. J Nutr Biochem 2014, 25:824-833.
27. Babu P.V., Si H., Liu D. Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-kappaB-mediated mechanism. Mol Nutr Food Res 2012, 56:1424-1432.
28. Delhase M., Hayakawa M., Chen Y., Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 1999, 284:309-313.
29. Aveleira C.A., Lin C.M., Abcouwer S.F., Ambrosio A.F., Antonetti D.A. TNF-alpha signals through PKCzeta/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 2010, 59:2872-2882.
30. Srinivasan S., Bolick D.T., Hatley M.E., Natarajan R., Reilly K.B., Yeh M., et al. Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes. J Biol Chem 2004, 279:31930-31936.
31. Thompson S.G., Kienast J., Pyke S.D., Haverkate F., van de Loo J.C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995, 332:635-641.
32. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
33. Deckert-Schluter M., Bluethmann H., Kaefer N., Rang A., Schluter D. Interferon-gamma receptor-mediated but not tumor necrosis factor receptor type 1- or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis. Am J Pathol 1999, 154:1549-1561.
34. Shaposhnik Z., Wang X., Lusis A.J. Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis. J Lipid Res 2010, 51:1962-1970.
35. Wu D., Nishimura N., Kuo V., Fiehn O., Shahbaz S., Van Winkle L., et al. Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol 2011, 31:1260-1267.
36. Moore K.J., Sheedy F.J., Fisher E.A. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013, 13:709-721.
37. Pittet M.J., Swirski F.K. Monocytes link atherosclerosis and cancer. Eur J Immunol 2011, 41:2519-2522.
38. Norata G.D., Cattaneo P., Poletti A., Catapano A.L. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta. Atherosclerosis 2010, 212:100-106.
39. Galkina E., Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2292-2301.
40. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., Yoshida M., Ding H.A., Gimbrone M.A., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398:718-723.
41. Martin J., Collot-Teixeira S., McGregor L., McGregor J.L. The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr Pharm Des 2007, 13:1751-1759.
42. Hong J.J., Jeong T.S., Choi J.H., Park J.H., Lee K.Y., Seo Y.J., et al. Hematein inhibits tumor necrotic factor-alpha-induced vascular cell adhesion molecule-1 and NF-kappaB-dependent gene expression in human vascular endothelial cells. Biochem Biophys Res Commun 2001, 281:1127-1133.
43. O'Brien K.D., Allen M.D., McDonald T.O., Chait A., Harlan J.M., Fishbein D., et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993, 92:945-951.
44. Huo Y., Weber C., Forlow S.B., Sperandio M., Thatte J., Mack M., et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest 2001, 108:1307-1314.
45. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009, 29:313-326.
46. Golias C., Tsoutsi E., Matziridis A., Makridis P., Batistatou A., Charalabopoulos K. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo 2007, 21:757-769.
47. Hegazy D.M., O'Reilly D.A., Yang B.M., Hodgkinson A.D., Millward B.A., Demaine A.G. NFkappaB polymorphisms and susceptibility to type 1 diabetes. Genes Immun 2001, 2:304-308.
48. Li Y., Reddy M.A., Miao F., Shanmugam N., Yee J.K., Hawkins D., et al. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 2008, 283:26771-26781.
49. Paria B.C., Malik A.B., Kwiatek A.M., Rahman A., May M.J., Ghosh S., et al. Tumor necrosis factor-alpha induces nuclear factor-kappaB-dependent TRPC1 expression in endothelial cells. J Biol Chem 2003, 278:37195-37203.
50. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 1997, 94:2927-2932.
51. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 1995, 267:1485-1488.
52. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102:1296-1301.
53. Read M.A., Whitley M.Z., Williams A.J., Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 1994, 179:503-512.
54. Diez J. Arterial stiffness and extracellular matrix. Adv Cardiol 2007, 44:76-95.
55. Nejjar I., Pieraggi M.T., Thiers J.C., Bouissou H. Age-related changes in the elastic tissue of the human thoracic aorta. Atherosclerosis 1990, 80:199-208.
56. Steed M.M., Tyagi S.C. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal 2011, 15:1927-1943.
57. Kaneko H., Anzai T., Morisawa M., Kohno T., Nagai T., Anzai A., et al. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization. Atherosclerosis 2011, 217:350-357.
58. Bellosta S., Baetta R., Canavesi M., Comparato C., Granata A., Monetti M., et al. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells. Pharmacol Res 2007, 56:160-167.
59. Pyo R., Lee J.K., Shipley J.M., Curci J.A., Mao D., Ziporin S.J., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000, 105:1641-1649.
60. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071.